<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase II:     Three-Dimensional Atom Probe Imaging for Nano-Biotechnology</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>10/01/2002</AwardEffectiveDate>
<AwardExpirationDate>05/31/2007</AwardExpirationDate>
<AwardTotalIntnAmount>499850.00</AwardTotalIntnAmount>
<AwardAmount>1001642</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Gregory T. Baxter</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>     This Small Business Innovation Research Phase II project will develop the Local Electrode Atom Probe (LEAP) to rapidly provide three-dimensional atomic-scale imaging and elemental identification of nano-biotechnology devices. Structural characterization of nano-biotechnology devices is currently problematic because available microscopy and analytical techniques have substantial limitations in quantitative imaging at the atomic-scale. Moreover, current microscopy techniques cannot adequately resolve three-dimensional biomacromolecules, which are intrinsic to nano-biotechnology devices. Until better analytical instrumentation is developed, researchers will "fly blind" as they develop more complex nano-biotechnology devices. The overall goal of this Phase II project is to rapidly analyze the three-dimensional atomic-scale structure and elemental composition of biological and organic molecules on nano-biotechnology devices. The focus will be on developing technologies to  analyze commercial specimens using LEAP technology, and to initiate commercialization and marketing of this technology to academic and industrial researchers.&lt;br/&gt;     The commercial application of this project will be in the area of bioanalytical instrumentation and nano-biotechnology devices.&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>09/17/2002</MinAmdLetterDate>
<MaxAmdLetterDate>05/23/2006</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0216620</AwardID>
<Investigator>
<FirstName>Thomas</FirstName>
<LastName>Kelly</LastName>
<PI_MID_INIT>F</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Thomas F Kelly</PI_FULL_NAME>
<EmailAddress>thomas.kelly@steaminstruments.com</EmailAddress>
<PI_PHON>6089609000</PI_PHON>
<NSF_ID>000091276</NSF_ID>
<StartDate>02/04/2005</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Steven</FirstName>
<LastName>Goodman</LastName>
<PI_MID_INIT>L</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Steven L Goodman</PI_FULL_NAME>
<EmailAddress>sgoodman@imagoscientific.com</EmailAddress>
<PI_PHON>6082746880</PI_PHON>
<NSF_ID>000101587</NSF_ID>
<StartDate>09/17/2002</StartDate>
<EndDate>02/04/2005</EndDate>
<RoleCode>Former Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Imago Scientific Instruments Corp</Name>
<CityName>Madison</CityName>
<CountyName/>
<ZipCode>537110000</ZipCode>
<PhoneNumber>6082746880</PhoneNumber>
<StreetAddress>5500 Nobel Drive</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Wisconsin</StateName>
<StateCode>WI</StateCode>
<CONGRESSDISTRICT>02</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>WI02</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>155513612</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>IMAGO SCIENTIFIC INSTRUMENTS CORPORATION</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM>001345149</ORG_PRNT_DUNS_NUM>
</Institution>
<Performance_Institution>
<Name><![CDATA[Imago Scientific Instruments Corp]]></Name>
<CityName>Madison</CityName>
<CountyName/>
<StateCode>WI</StateCode>
<ZipCode>537110000</ZipCode>
<StreetAddress><![CDATA[5500 Nobel Drive]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Wisconsin</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>02</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>WI02</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0203000</Code>
<Name>Health</Name>
</FoaInformation>
<ProgramElement>
<Code>5373</Code>
<Text>SBIR Phase II</Text>
</ProgramElement>
<ProgramReference>
<Code>9178</Code>
<Text>UNDERGRADUATE EDUCATION</Text>
</ProgramReference>
<ProgramReference>
<Code>9181</Code>
<Text>BIOPROCESSING/BIOMOLECULAR MATERIALS</Text>
</ProgramReference>
<ProgramReference>
<Code>9251</Code>
<Text>REU SUPP-Res Exp for Ugrd Supp</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
<Appropriation>
<Code>0102</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0103</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0104</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0106</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2002~499850</FUND_OBLG>
<FUND_OBLG>2003~12000</FUND_OBLG>
<FUND_OBLG>2004~477792</FUND_OBLG>
<FUND_OBLG>2006~12000</FUND_OBLG>
</Award>
</rootTag>
